{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:11:25Z","timestamp":1787245885764,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18390044"],"award-info":[{"award-number":["18390044"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04002"],"award-info":[{"award-number":["17H04002"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H04682"],"award-info":[{"award-number":["18H04682"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The emergence of drug-resistant influenza type A viruses (IAVs) necessitates the development of novel anti-IAV agents. Here, we target the IAV hemagglutinin (HA) protein using multivalent peptide library screens and identify PVF-tet, a peptide-based HA inhibitor. PVF-tet inhibits IAV cytopathicity and propagation in cells by binding to newly synthesized HA, rather than to the HA of the parental virus, thus inducing the accumulation of HA within a unique structure, the inducible amphisome, whose production from the autophagosome is accelerated by PVF-tet. The amphisome is also produced in response to IAV infection in the absence of PVF-tet by cells overexpressing ABC transporter subfamily A3, which plays an essential role in the maturation of multivesicular endosomes into the lamellar body, a lipid-sorting organelle. Our results show that the inducible amphisomes can function as a type of organelle-based anti-viral machinery by sequestering HA. PVF-tet efficiently rescues mice from the lethality of IAV infection.<\/jats:p>","DOI":"10.1038\/s41467-019-13974-w","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T11:02:26Z","timestamp":1578567746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-6045","authenticated-orcid":false,"given":"Jumpei","family":"Omi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Watanabe-Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsura","family":"Igai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yi","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Waku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieka","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Natori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"13974_CR1","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier, N. M. & Palese, P. The biology of influenza viruses. Vaccine 26, D49\u2013D53 (2008).","journal-title":"Vaccine"},{"key":"13974_CR2","doi-asserted-by":"publisher","first-page":"e1001558","DOI":"10.1371\/journal.pmed.1001558","volume":"10","author":"L Simonsen","year":"2013","unstructured":"Simonsen, L. et al. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med. 10, e1001558 (2013).","journal-title":"PLoS Med."},{"key":"13974_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJM199709253371302","volume":"337","author":"FG Hayden","year":"1997","unstructured":"Hayden, F. G. et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N. Engl. J. Med. 337, 874\u2013880 (1997).","journal-title":"N. Engl. J. Med."},{"key":"13974_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/AAC.42.3.647","volume":"42","author":"W Li","year":"1998","unstructured":"Li, W. et al. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother. 42, 647\u2013653 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13974_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/AAC.01311-09","volume":"54","author":"S Kubo","year":"2010","unstructured":"Kubo, S., Tomozawa, T., Kakuta, M., Tokumitsu, A. & Yamashita, M. Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration. Antimicrob. Agents Chemother. 54, 1256\u20131264 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"13974_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","volume":"16","author":"T Watanabe","year":"2014","unstructured":"Watanabe, T. et al. Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe 16, 795\u2013805 (2014).","journal-title":"Cell Host Microbe"},{"key":"13974_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tim.2018.03.005","volume":"26","author":"CJ Russell","year":"2018","unstructured":"Russell, C. J., Hu, M. & Okda, F. A. Influenza hemagglutinin protein stability, activation, and pandemic risk. Trends Microbiol. 26, 841\u2013853 (2018).","journal-title":"Trends Microbiol."},{"key":"13974_CR8","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1126\/science.1093155","volume":"303","author":"SJ Gamblin","year":"2004","unstructured":"Gamblin, S. J. et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (N.Y.) 303, 1838\u20131842 (2004).","journal-title":"Science (N.Y.)"},{"key":"13974_CR9","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1021\/bi00447a018","volume":"28","author":"NK Sauter","year":"1989","unstructured":"Sauter, N. K. et al. Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry 28, 8388\u20138396 (1989).","journal-title":"Biochemistry"},{"key":"13974_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1006\/viro.1996.0139","volume":"217","author":"DK Takemoto","year":"1996","unstructured":"Takemoto, D. K., Skehel, J. J. & Wiley, D. C. A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. Virology 217, 452\u2013458 (1996).","journal-title":"Virology"},{"key":"13974_CR11","doi-asserted-by":"publisher","unstructured":"Sieben, C., Sezgin, E., Eggeling, C. & Manley, S. Influenza A viruses use multivalent sialic acid clusters for cell binding and receptor activation. bioRxiv, https:\/\/doi.org\/10.1101\/264713 (2018).","DOI":"10.1101\/264713"},{"key":"13974_CR12","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1021\/jm1002183","volume":"53","author":"T Matsubara","year":"2010","unstructured":"Matsubara, T. et al. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. J. Med. Chem. 53, 4441\u20134449 (2010).","journal-title":"J. Med. Chem."},{"key":"13974_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep22790","volume":"6","author":"D Lin","year":"2016","unstructured":"Lin, D. et al. A \"building block\" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities. Sci. Rep. 6, 22790 (2016).","journal-title":"Sci. Rep."},{"key":"13974_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1126\/science.aan0516","volume":"358","author":"RU Kadam","year":"2017","unstructured":"Kadam, R. U. et al. Potent peptidic fusion inhibitors of influenza virus. Science (N.Y.) 358, 496\u2013502 (2017).","journal-title":"Science (N.Y.)"},{"key":"13974_CR15","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1096\/fj.06-6572fje","volume":"20","author":"K Nishikawa","year":"2006","unstructured":"Nishikawa, K. et al. A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. FASEB J. 20, 2597\u20132599 (2006).","journal-title":"FASEB J."},{"key":"13974_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/IAI.01022-09","volume":"78","author":"M Watanabe-Takahashi","year":"2010","unstructured":"Watanabe-Takahashi, M. et al. An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin. Infect. Immun. 78, 177\u2013183 (2010).","journal-title":"Infect. Immun."},{"key":"13974_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1128\/IAI.01256-12","volume":"81","author":"K Tsutsuki","year":"2013","unstructured":"Tsutsuki, K., Watanabe-Takahashi, M., Takenaka, Y., Kita, E. & Nishikawa, K. Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions. Infect. Immun. 81, 2133\u20132138 (2013).","journal-title":"Infect. Immun."},{"key":"13974_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/AEM.03517-14","volume":"81","author":"M Kato","year":"2015","unstructured":"Kato, M., Watanabe-Takahashi, M., Shimizu, E. & Nishikawa, K. Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane. Appl. Environ. Microbiol. 81, 1092\u20131100 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"13974_CR19","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1128\/IAI.00149-16","volume":"84","author":"T Mitsui","year":"2016","unstructured":"Mitsui, T. et al. Affinity-based screening of tetravalent peptides identifies subtype-selective neutralizers of shiga toxin 2d, a highly virulent subtype, by targeting a unique amino acid involved in its receptor recognition. Infect. Immun. 84, 2653\u20132661 (2016).","journal-title":"Infect. Immun."},{"key":"13974_CR20","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1128\/JVI.00593-13","volume":"87","author":"X Sun","year":"2013","unstructured":"Sun, X. et al. N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J. Virol. 87, 8756\u20138766 (2013).","journal-title":"J. Virol."},{"key":"13974_CR21","doi-asserted-by":"publisher","first-page":"34978","DOI":"10.1074\/jbc.M114.586180","volume":"289","author":"K Brett","year":"2014","unstructured":"Brett, K. et al. Site-specific S-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate. J. Biol. Chem. 289, 34978\u201334989 (2014).","journal-title":"J. Biol. Chem."},{"key":"13974_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1083\/jcb.140.6.1357","volume":"140","author":"P Keller","year":"1998","unstructured":"Keller, P. & Simons, K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 140, 1357\u20131367 (1998).","journal-title":"J. Cell Biol."},{"key":"13974_CR23","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1083\/jcb.142.6.1413","volume":"142","author":"F Lafont","year":"1998","unstructured":"Lafont, F., Lecat, S., Verkade, P. & Simons, K. Annexin XIIIb associates with lipid microdomains to function in apical delivery. J. Cell Biol. 142, 1413\u20131427 (1998).","journal-title":"J. Cell Biol."},{"key":"13974_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1083\/jcb.200108042","volume":"155","author":"Y Noda","year":"2001","unstructured":"Noda, Y. et al. KIFC3, a microtubule minus end-directed motor for the apical transport of annexin XIIIb-associated Triton-insoluble membranes. J. Cell Biol. 155, 77\u201388 (2001).","journal-title":"J. Cell Biol."},{"key":"13974_CR25","doi-asserted-by":"publisher","first-page":"21883","DOI":"10.1074\/jbc.273.34.21883","volume":"273","author":"TO Berg","year":"1998","unstructured":"Berg, T. O., Fengsrud, M., Stromhaug, P. E., Berg, T. & Seglen, P. O. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J. Biol. Chem. 273, 21883\u201321892 (1998).","journal-title":"J. Biol. Chem."},{"key":"13974_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.cr.7290023","volume":"9","author":"J Yi","year":"1999","unstructured":"Yi, J. & Tang, X. M. The convergent point of the endocytic and autophagic pathways in leydig cells. Cell Res. 9, 243\u2013253 (1999).","journal-title":"Cell Res."},{"key":"13974_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0854.2007.00677.x","volume":"9","author":"CM Fader","year":"2008","unstructured":"Fader, C. M., Sanchez, D., Furlan, M. & Colombo, M. I. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic (Cph., Den.) 9, 230\u2013250 (2008).","journal-title":"Traffic (Cph., Den.)"},{"key":"13974_CR28","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/infdis\/jis455","volume":"206","author":"VK Weinheimer","year":"2012","unstructured":"Weinheimer, V. K. et al. Influenza A viruses target type II pneumocytes in the human lung. J. Infect. Dis. 206, 1685\u20131694 (2012).","journal-title":"J. Infect. Dis."},{"key":"13974_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1091\/mbc.11.1.255","volume":"11","author":"M Hariri","year":"2000","unstructured":"Hariri, M. et al. Biogenesis of multilamellar bodies via autophagy. Mol. Biol. Cell 11, 255\u2013268 (2000).","journal-title":"Mol. Biol. Cell"},{"key":"13974_CR30","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1242\/jcs.02324","volume":"118","author":"P Lajoie","year":"2005","unstructured":"Lajoie, P., Guay, G., Dennis, J. W. & Nabi, I. R. The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J. Cell Sci. 118, 1991\u20132003 (2005).","journal-title":"J. Cell Sci."},{"key":"13974_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/cdd.2008.168","volume":"16","author":"CM Fader","year":"2009","unstructured":"Fader, C. M. & Colombo, M. I. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 16, 70\u201378 (2009).","journal-title":"Cell Death Differ."},{"key":"13974_CR32","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1074\/jbc.M507515200","volume":"281","author":"N Cheong","year":"2006","unstructured":"Cheong, N. et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J. Biol. Chem. 281, 9791\u20139800 (2006).","journal-title":"J. Biol. Chem."},{"key":"13974_CR33","doi-asserted-by":"publisher","first-page":"L628","DOI":"10.1152\/ajplung.00373.2014","volume":"308","author":"CC Hofer","year":"2015","unstructured":"Hofer, C. C., Woods, P. S. & Davis, I. C. Infection of mice with influenza A\/WSN\/33 (H1N1) virus alters alveolar type II cell phenotype. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L628\u2013L638 (2015).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13974_CR34","doi-asserted-by":"publisher","first-page":"L1160","DOI":"10.1152\/ajplung.00339.2016","volume":"311","author":"PS Woods","year":"2016","unstructured":"Woods, P. S. et al. Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome. Am. J. Physiol. Lung Cell. Mol. Physiol. 311, L1160\u2013l1169 (2016).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13974_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/viro.1997.8958","volume":"241","author":"J Martin","year":"1998","unstructured":"Martin, J. et al. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241, 101\u2013111 (1998).","journal-title":"Virology"},{"key":"13974_CR36","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1016\/S0021-9258(18)42250-8","volume":"267","author":"H Kido","year":"1992","unstructured":"Kido, H. et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J. Biol. Chem. 267, 13573\u201313579 (1992).","journal-title":"J. Biol. Chem."},{"key":"13974_CR37","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.1073\/pnas.95.17.10224","volume":"95","author":"H Goto","year":"1998","unstructured":"Goto, H. & Kawaoka, Y. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl Acad. Sci. USA 95, 10224\u201310228 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13974_CR38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0021-9258(17)37874-2","volume":"254","author":"JU Baenziger","year":"1979","unstructured":"Baenziger, J. U. & Fiete, D. Structure of the complex oligosaccharides of fetuin. J. Biol. Chem. 254, 789\u2013795 (1979).","journal-title":"J. Biol. Chem."},{"key":"13974_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0014-5793(90)80486-3","volume":"272","author":"MN Matrosovich","year":"1990","unstructured":"Matrosovich, M. N., Mochalova, L. V., Marinina, V. P., Byramova, N. E. & Bovin, N. V. Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity. FEBS Lett. 272, 209\u2013212 (1990).","journal-title":"FEBS Lett."},{"key":"13974_CR40","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1021\/bi0256173","volume":"41","author":"S Futaki","year":"2002","unstructured":"Futaki, S., Nakase, I., Suzuki, T., Youjun, Z. & Sugiura, Y. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41, 7925\u20137930 (2002).","journal-title":"Biochemistry"},{"key":"13974_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/bc700289w","volume":"19","author":"M Kosuge","year":"2008","unstructured":"Kosuge, M., Takeuchi, T., Nakase, I., Jones, A. T. & Futaki, S. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug. Chem. 19, 656\u2013664 (2008).","journal-title":"Bioconjug. Chem."},{"key":"13974_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0042-6822(03)00264-2","volume":"313","author":"O Zhirnov","year":"2003","unstructured":"Zhirnov, O. & Klenk, H. D. Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells. Virology 313, 198\u2013212 (2003).","journal-title":"Virology"},{"key":"13974_CR43","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1093\/emboj\/16.18.5501","volume":"16","author":"P Scheiffele","year":"1997","unstructured":"Scheiffele, P., Roth, M. G. & Simons, K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 16, 5501\u20135508 (1997).","journal-title":"EMBO J."},{"key":"13974_CR44","first-page":"132","volume":"25","author":"J Perez-Gil","year":"2010","unstructured":"Perez-Gil, J. & Weaver, T. E. Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda, Md.) 25, 132\u2013141 (2010).","journal-title":"Physiology (Bethesda, Md.)"},{"key":"13974_CR45","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1242\/jcs.019265","volume":"120","author":"RA Nixon","year":"2007","unstructured":"Nixon, R. A. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 120, 4081\u20134091 (2007).","journal-title":"J. Cell Sci."},{"key":"13974_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/auto.5.3.7406","volume":"5","author":"Z Zhou","year":"2009","unstructured":"Zhou, Z. et al. Autophagy is involved in influenza A virus replication. Autophagy 5, 321\u2013328 (2009).","journal-title":"Autophagy"},{"key":"13974_CR47","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1128\/JVI.02148-13","volume":"87","author":"OP Zhirnov","year":"2013","unstructured":"Zhirnov, O. P. & Klenk, H. D. Influenza A virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells. J. Virol. 87, 13107\u201313114 (2013).","journal-title":"J. Virol."},{"key":"13974_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biocel.2016.01.012","volume":"72","author":"G Liu","year":"2016","unstructured":"Liu, G. et al. Autophagy is involved in regulating influenza A virus RNA and protein synthesis associated with both modulation of Hsp90 induction and mTOR\/p70S6K signaling pathway. Int. J. Biochem. Cell Biol. 72, 100\u2013108 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"13974_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","volume":"15","author":"R Beale","year":"2014","unstructured":"Beale, R. et al. A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe 15, 239\u2013247 (2014).","journal-title":"Cell Host Microbe"},{"key":"13974_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","volume":"6","author":"M Gannage","year":"2009","unstructured":"Gannage, M. et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6, 367\u2013380 (2009).","journal-title":"Cell Host Microbe"},{"key":"13974_CR51","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1128\/JVI.00576-15","volume":"90","author":"Y Ren","year":"2016","unstructured":"Ren, Y. et al. Proton channel activity of influenza A virus matrix protein 2 contributes to autophagy arrest. J. Virol. 90, 591\u2013598 (2016).","journal-title":"J. Virol."},{"key":"13974_CR52","doi-asserted-by":"publisher","first-page":"e89462","DOI":"10.1172\/jci.insight.89462","volume":"2","author":"H Kimura","year":"2017","unstructured":"Kimura, H. et al. Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy. JCI Insight 2, e89462 (2017).","journal-title":"JCI Insight"},{"key":"13974_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ceb.2009.12.004","volume":"22","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N. The role of the Atg1\/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 22, 132\u2013139 (2010).","journal-title":"Curr. Opin. Cell Biol."},{"key":"13974_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"RC Russell","year":"2013","unstructured":"Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741\u2013750 (2013).","journal-title":"Nat. Cell Biol."},{"key":"13974_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbamcr.2017.10.014","volume":"1865","author":"B Yeganeh","year":"2018","unstructured":"Yeganeh, B. et al. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochim. Et. Biophys. Acta 1865, 364\u2013378 (2018).","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"13974_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nbt.3907","volume":"35","author":"EM Strauch","year":"2017","unstructured":"Strauch, E. M. et al. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nat. Biotechnol. 35, 667\u2013671 (2017).","journal-title":"Nat. Biotechnol."},{"key":"13974_CR57","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1128\/JVI.00586-14","volume":"88","author":"T Ohkura","year":"2014","unstructured":"Ohkura, T., Momose, F., Ichikawa, R., Takeuchi, K. & Morikawa, Y. Influenza A virus hemagglutinin and neuraminidase mutually accelerate their apical targeting through clustering of lipid rafts. J. Virol. 88, 10039\u201310055 (2014).","journal-title":"J. Virol."},{"key":"13974_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/labinvest.3780044","volume":"80","author":"MT Stahlman","year":"2000","unstructured":"Stahlman, M. T., Gray, M. P., Falconieri, M. W., Whitsett, J. A. & Weaver, T. E. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab. Investig. 80, 395\u2013403 (2000).","journal-title":"Lab. Investig."},{"key":"13974_CR59","doi-asserted-by":"publisher","first-page":"e61092","DOI":"10.1371\/journal.pone.0061092","volume":"8","author":"T Takahashi","year":"2013","unstructured":"Takahashi, T., Takaguchi, M., Kawakami, T. & Suzuki, T. Sulfatide regulates caspase-3-independent apoptosis of influenza A virus through viral PB1-F2 protein. PLoS ONE 8, e61092 (2013).","journal-title":"PLoS ONE"},{"key":"13974_CR60","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1128\/JVI.02496-07","volume":"82","author":"T Takahashi","year":"2008","unstructured":"Takahashi, T. et al. Sulfatide is required for efficient replication of influenza A virus. J. Virol. 82, 5940\u20135950 (2008).","journal-title":"J. Virol."},{"key":"13974_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2014.03.009","volume":"54","author":"LC Gomes","year":"2014","unstructured":"Gomes, L. C. & Dikic, I. Autophagy in antimicrobial immunity. Mol. Cell 54, 224\u2013233 (2014).","journal-title":"Mol. Cell"},{"key":"13974_CR62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2010.04.018","volume":"141","author":"E Dixit","year":"2010","unstructured":"Dixit, E. et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668\u2013681 (2010).","journal-title":"Cell"},{"key":"13974_CR63","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2010.04.043","volume":"141","author":"S Sharma","year":"2010","unstructured":"Sharma, S. & Fitzgerald, K. A. Viral defense: it takes two MAVS to Tango. Cell 141, 570\u2013572 (2010).","journal-title":"Cell"},{"key":"13974_CR64","doi-asserted-by":"publisher","first-page":"L99","DOI":"10.1529\/biophysj.106.096206","volume":"91","author":"SV Koushik","year":"2006","unstructured":"Koushik, S. V., Chen, H., Thaler, C., Puhl, H. L. 3rd & Vogel, S. S. Cerulean, Venus, and VenusY67C FRET reference standards. Biophys. J. 91, L99\u2013l101 (2006).","journal-title":"Biophys. J."},{"key":"13974_CR65","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13974-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:40:42Z","timestamp":1670258442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13974-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["13974"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13974-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}